|
|
Long-term outcomes with first-generation drug-eluting stents in primary PCI for STEMI show that they have benefits over and above bare-metal stents, say the authors of a new meta-analysis. But an accompanying editorialist is not so sure. Heartwire
Read from Source
|
| |
| |
| | 148 |
| |
|
|
|
|
|
|
